OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
June 01, 2023
Each month, our editorial staff compiles a recap of the top news in endocrinology from the past month. Our April 2023 month in review features new FDA approvals, important phase 2 data, and in-depth clinician perspective.
May 26, 2023
As a follow-up to an episode earlier this year and the FDA clearances of the technology that forms the iLet Bionic Pancreas, hosts sat down in the MJH Life Sciences studio for a special edition recording to explore the implications of the clearance, dispel misconceptions surrounding the system, and hypothesize about the future of this technology in people with diabetes.
May 19, 2023
Announced by the US FDA on May 19, 2023, the clearance of the iLet ACE Pump and the iLet Dosing Decision Software, when combined with a compatible CGM, will form the iLet Bionic Pancreas.
May 18, 2023
Diabetes care experts discuss practical strategies to help young adults with type 1 diabetes transition from pediatric to adult endocrinology care, and how families can support them during this transition.
Dr Julia Blanchette explains how a micro video toolkit developed by her team can help young adults alleviate the financial stress of type 1 diabetes.
Julia Blanchette, PhD, RN; Natalie Bellini, DNP, FNP-BC; and Diana Isaacs, PharmD, BC-ADM, CDCES discuss the challenges young adults with type 1 diabetes encounter, including managing their healthcare finances.
Dr Julia Blanchette highlights some of the latest advancements in automated insulin delivery systems that can aid in the self-management of type 1 diabetes.
May 16, 2023
An analysis of more than 800,000 person-years of follow-up data from people in the United Kingdom with type 1 diabetes offers an overview of cancer incidence and mortality among this cohort.
In a recent interview, Kris Kowdley, MD, discusses current data surrounding use of GLP-1 receptor agonists in NAFLD and NASH as well as the prospective role of combination agents.
May 12, 2023
In this episode, hosts sit down with Robert Vigersky, MD, chief medical officer of Medtronic Diabetes, for a discussion around the MiniMed 780G, including use, exclusive features, and how patients can obtain the new system.